Format

Send to

Choose Destination
J Autism Dev Disord. 2015 Oct;45(10):3262-75. doi: 10.1007/s10803-015-2489-3.

Parents' perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders.

Author information

1
Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Penn Tower Room 1112, Philadelphia, PA, 19104, USA. marian.reiff@uphs.upenn.edu.
2
College of Nursing and Health Professions, Drexel University, Philadelphia, PA, USA.
3
Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Penn Tower Room 1112, Philadelphia, PA, 19104, USA.
4
Mixed Methods Research Lab, University of Pennsylvania, Philadelphia, PA, USA.
5
Division of Genomic Diagnostics and Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
6
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
7
Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA, USA.

Abstract

Clinical guidelines recommend chromosomal microarray analysis (CMA) for all children with autism spectrum disorders (ASDs). We explored the test's perceived usefulness among parents of children with ASD who had undergone CMA, and received a result categorized as pathogenic, variant of uncertain significance, or negative. Fifty-seven parents participated in a semi-structured telephone interview, and 50 also completed a survey. Most parents reported that CMA was helpful for their child and family. Major themes regarding perceived usefulness were: medical care, educational and behavioral interventions, causal explanation, information for family members, and advancing knowledge. Limits to utility, uncertainties and negative outcomes were also identified. Our findings highlight the importance of considering both health and non-health related utility in genomic testing.

KEYWORDS:

Autism spectrum disorders; Chromosomal microarray analysis; Genomic testing; Parent perspectives; Perceived utility; Qualitative

PMID:
26066358
PMCID:
PMC4573251
DOI:
10.1007/s10803-015-2489-3
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center